Chief Operating Officer, Head of Research
Dr. Matthew Wright is Chief Operating Officer, Head of Research at Strekin. Dr. Wright is a seasoned scientific leader with 15 years of experience in drug discovery research. Dr. Wright most recently served as Research Leader and Scientific Expert at Hoffmann La Roche. During this time, he led teams that implemented novel drug discovery approaches for the identification of small molecule modulators of nuclear hormone receptors, and for identification of drug targets in cardiovascular and metabolic health. During his tenure, he also directed academic collaborations, drug discovery and strategic alliances. Dr. Wright previously held a post-doctoral fellowship at the University of Washington, Department of Pathology, with Dr. D. F. Bowen-Pope, researching mechanisms of vessel restenosis and tissue repair. He has authored numerous articles in the fields of NHR drug discovery, signal transduction and vascular biology, and is an inventor on over 25 issued and pending patents. He holds a Ph.D. in biochemistry, molecular biology, and cell biology from Northwestern University.